Echocardiography and Noninvasive Imaging in Cardiac Resynchronization Therapy. Results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) Study in Perspective

Journal of the American College of Cardiology

Volumn 53, Issue 21, 2009, Pages 1933-1943

  Bax, Jeroen J ^a   Gorcsan III, John ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

cardiac dyssynchrony; cardiac resynchronization therapy; heart failure; tissue Doppler imaging

Indexed keywords

CARDIAC DYSSYNCHRONY; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL RESEARCH; CLINICAL STUDY; ECHOCARDIOGRAPHY; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; NON INVASIVE PROCEDURE; PATHOPHYSIOLOGY; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE;

ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; ELECTRIC COUNTERSHOCK; HEART FAILURE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; VENTRICULAR FUNCTION, LEFT;

EID: 65549113299     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.11.061     Document Type: Review

References (66)

1. Auricchio A., Stellbrink C., Sack S., et al., Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 39 (2002) 2026-2033
2. Cazeau S., Leclercq C., Lavergne T., et al., Multisite Simulation in Cardiomyopathies MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344 (2001) 873-880
3. Abraham W.T., Fisher W.G., Smith A.L., et al., MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
4. Young J.B., Abraham W.T., Smith A.L., et al., Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. JAMA 289 (2003) 2685-2694
5. Bristow M.R., Saxon L.A., Boehmer J., et al., Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
6. Cleland J., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
7. Auricchio A., Stellbrink C., Butter C., et al., Pacing Therapies in Congestive Heart Failure II Study Group, Guidant Heart Failure Research Group. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 42 (2003) 2109-2116
8. Lozano I., Bocchiardo M., Achtelik M., et al., VENTAK CHF/CONTAK CD Investigators Study Group. Impact of biventricular pacing on mortality in a randomized crossover study of patients with heart failure and ventricular arrhythmias. Pacing Clin Electrophysiol 23 (2000) 1711-1712
9. Rivero-Ayerza M., Theuns D.A., Garcia-Garcia H.M., Boersma E., Simoons M., and Jordaens L.J. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J 27 (2006) 2682-2688
10. McAlister F.A., Ezekowitz J.A., Wiebe N., et al. Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med 141 (2004) 381-390
11. Strickberger S.A., Conti J., Daoud E.G., et al. Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation 111 (2005) 2146-2150
12. Bax J.J., Abraham T., Barold S.S., et al. Cardiac resynchronization therapy part 1-issues before device implantation. J Am Coll Cardiol 46 (2005) 2153-2167
13. Chung E., Leon A.R., Tavazzi L., et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 117 (2008) 2608-2616
14. Bleeker G.B., Bax J.J., Fung J.W., et al. Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. Am J Cardiol 97 (2006) 260-263
15. Ypenburg C., Westenberg J.J., Bleeker G.B., et al. Noninvasive imaging in cardiac resynchronization therapy-part 1: selection of patients. Pacing Clin Electrophysiol 31 (2008) 1475-1499
16. Higgins S.L., Hummel J.D., Niazi I.K., et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 42 (2003) 1454-1459
17. Pires L.A., Abraham W.T., Young J.B., and Johnson K.M. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials. Am Heart J 151 (2006) 837-843
18. Leon A.R., Abraham W.T., Brozena S., et al. Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure. J Am Coll Cardiol 46 (2005) 2298-2304
19. Ypenburg C., van Erven L., Bleeker G.B., et al. Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias. J Am Coll Cardiol 48 (2006) 464-470
20. Bleeker G.B., Schalij M.J., Boersma E., Steendijk P., van der Wall E.E., and Bax J.J. Does a gender difference in response to cardiac resynchronization therapy exist?. Pacing Clin Electrophysiol 28 (2005) 1271-1275
21. Bleeker G.B., Schalij M.J., Molhoek S.G., et al. Comparison of effectiveness of cardiac resynchronization therapy in patients <70 versus > or =70 years of age. Am J Cardiol 96 (2005) 420-422
22. Lellouche N., De Diego C., Cesario D.A., et al. Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy. Am J Cardiol 99 (2007) 242-246
23. Molhoek S.G., Bax J.J., Bleeker G.B., et al. Long-term follow-up of cardiac resynchronization therapy in patients with end-stage heart failure. J Cardiovasc Electrophysiol 16 (2005) 701-707
24. Boriani G., Saporito D., Biffi M., et al. Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients. Int J Cardiol 110 (2006) 318-323
25. Gasparini M., Lunati M., Bocchiardo M., et al. Cardiac resynchronization and implantable cardioverter defibrillator therapy: preliminary results from the InSync Implantable Cardioverter Defibrillator Italian Registry. Pacing Clin Electrophysiol 26 (2003) 148-151
26. Yeim S., Bordachar P., Reuter S., et al. Predictors of a positive response to biventricular pacing in patients with severe heart failure and ventricular conduction delay. Pacing Clin Electrophysiol 30 (2007) 970-975
27. Yu C.M., Gorcsan III J., Bleeker G.B., et al. Usefulness of tissue Doppler velocity and strain dyssynchrony for predicting left ventricular reverse remodeling response after cardiac resynchronization therapy. Am J Cardiol 100 (2007) 1263-1270
28. Yu C.M., Bleeker G.B., Fung J.W., et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 112 (2005) 1580-1586
29. Yu C.M., Fang F., Zhang Q., et al. Improvement of atrial function and atrial reverse remodeling after cardiac resynchronization therapy for heart failure. J Am Coll Cardiol 50 (2007) 778-785
30. Fung J.W., Szeto C.C., Chan J.Y., et al. Prognostic value of renal function in patients with cardiac resynchronization therapy. Int J Cardiol 122 (2007) 10-16
31. Yu C.M., Zhang Q., Yip G.W., et al. Are left ventricular diastolic function and diastolic asynchrony important determinants of response to cardiac resynchronization therapy?. Am J Cardiol 98 (2006) 1083-1087
32. Jansen A.H., Bracke F., van Dantzig J.M., et al. Optimization of pulsed wave tissue Doppler to predict left ventricular reverse remodeling after cardiac resynchronization therapy. J Am Soc Echocardiogr 19 (2006) 185-191
33. Fung J.W., Chan J.Y., Kum L.C., et al. Suboptimal medical therapy in patients with systolic heart failure is associated with less improvement by cardiac resynchronization therapy. Int J Cardiol 115 (2007) 214-219
34. Soliman O.I., Theuns D.A., Geleijnse M.L., et al. Spectral pulsed-wave tissue Doppler imaging lateral-to-septal delay fails to predict clinical or echocardiographic outcome after cardiac resynchronization therapy. Europace 9 (2007) 113-118
35. Jansen A.H., Bracke F., van Dantzig J.M., et al. The influence of myocardial scar and dyssynchrony on reverse remodeling in cardiac resynchronization therapy. Eur J Echocardiogr 9 (2008) 483-488
36. Yu C.M., Zhang Q., Fung J.W., et al. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging. J Am Coll Cardiol 45 (2005) 677-684
37. Yu C.M., Zhang Q., Chan Y.S., et al. Tissue Doppler velocity is superior to displacement and strain mapping in predicting left ventricular reverse remodelling response after cardiac resynchronisation therapy. Heart 92 (2006) 1452-1456
38. Murphy R.T., Sigurdsson G., Mulamalla S., et al. Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchronization therapy. Am J Cardiol 97 (2006) 1615-1621
39. Yu C.M., Fung J.W., Zhang Q., et al. Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation 110 (2004) 66-73
40. Zhang Q., Fung J.W., Auricchio A., et al. Differential change in left ventricular mass and regional wall thickness after cardiac resynchronization therapy for heart failure. Eur Heart J 27 (2006) 1423-1430
41. Rouleau F., Merheb M., Geffroy S., et al. Echocardiographic assessment of the interventricular delay of activation and correlation to the QRS width in dilated cardiomyopathy. Pacing Clin Electrophysiol 24 (2001) 1500-1506
42. Bleeker G.B., Schalij M.J., Molhoek S.G., et al. Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. J Cardiovasc Electrophysiol 15 (2004) 544-549
43. Mollema S.A., Bleeker G.B., van der Wall E.E., Schalij M.J., and Bax J.J. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure. Am J Cardiol 100 (2007) 1665-1670
44. Helm R.H., Leclercq C., Faris O.P., et al. Cardiac dyssynchrony analysis using circumferential versus longitudinal strain: implications for assessing cardiac resynchronization. Circulation 111 (2005) 2760-2767
45. Pitzalis M.V., Iacoviello M., Romito R., et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 40 (2002) 1615-1622
46. Marcus G.M., Rose E., Viloria E.M., et al. Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy. J Am Coll Cardiol 46 (2005) 2208-2214
47. Penicka M., Bartunek J., De Bruyne B., et al. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography. Circulation 109 (2004) 978-983
48. Bax J.J., Marwick T.H., Molhoek S.G., et al. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol 92 (2003) 1238-1240
49. Notabartolo D., Merlino J.D., Smith A.L., et al. Usefulness of the peak velocity difference by tissue Doppler imaging technique as an effective predictor of response to cardiac resynchronization therapy. Am J Cardiol 94 (2004) 817-820
50. Van de Veire N.R., Yu C.M., Ajmone-Marsan N., et al. Tri-plane tissue Doppler imaging: a novel 3-dimensional imaging modality that predicts reverse left ventricular remodeling after cardiac resynchronization therapy. Heart 94 (2008) e9
51. Gorcsan III J., Kanzaki H., Bazaz R., Dohi K., and Schwartzman D. Usefulness of echocardiographic tissue synchronization imaging to predict acute response to cardiac resynchronization therapy. Am J Cardiol 93 (2004) 1178-1181
52. Suffoletto M.S., Dohi K., Cannesson M., Saba S., and Gorcsan III J. Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation 113 (2006) 960-968
53. Gorcsan III J., Tanabe M., Bleeker G.B., et al. Combined longitudinal and radial dyssynchrony predicts ventricular response after resynchronization therapy. J Am Coll Cardiol 50 (2007) 1476-1483
54. Marsan N.A., Bleeker G.B., Ypenburg C., et al. Real-time three-dimensional echocardiography permits quantification of left ventricular mechanical dyssynchrony and predicts acute response to cardiac resynchronization therapy. J Cardiovasc Electrophysiol 19 (2008) 392-399
55. Miyazaki C., Powell B.D., Bruce C.J., et al. Comparison of echocardiographic dyssynchrony assessment by tissue velocity and strain imaging in subjects with or without systolic dysfunction and with or without left bundle-branch block. Circulation 117 (2008) 2617-2625
56. Anderson L.J., Miyazaki C., Sutherland G.R., and Oh J.K. Patient selection and echocardiographic assessment of dyssynchrony in cardiac resynchronization therapy. Circulation 117 (2008) 2009-2023
57. Kapetanakis S., Kearney M.T., Siva A., Gall N., Cooklin M., and Monaghan M.J. Real-time three-dimensional echocardiography: a novel technique to quantify global left ventricular mechanical dyssynchrony. Circulation 112 (2005) 992-1000
58. Chalil S., Stegemann B., Muhyaldeen S., et al. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging. J Am Coll Cardiol 50 (2007) 243-252
59. Chen J., Henneman M.M., Trimble M.A., et al. Assessment of left ventricular mechanical dyssynchrony by phase analysis of ECG-gated SPECT myocardial perfusion imaging. J Nucl Cardiol 15 (2008) 127-136
60. Henneman M.M., Chen J., Dibbets-Schneider P., et al. Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT?. J Nucl Med 48 (2007) 1104-1111
61. White J.A., Yee R., Yuan X., et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol 48 (2006) 1953-1960
62. Bleeker G.B., Kaandorp T.A., Lamb H.J., et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 113 (2006) 969-976
63. Ypenburg C., Roes S.D., Bleeker G.B., et al. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J Cardiol 99 (2007) 657-660
64. Becker M., Kramann R., Franke A., et al. Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography. Eur Heart J 28 (2007) 1211-1220
65. Van de Veire N.R., Schuijf J.D., De Sutter J., et al. Non-invasive visualization of the cardiac venous system in coronary artery disease patients using 64-slice computed tomography. J Am Coll Cardiol 48 (2006) 1832-1838
66. Van de Veire N.R., Marsan N.A., Schuijf J.D., et al. Noninvasive imaging of cardiac venous anatomy with 64-slice multi-slice computed tomography and noninvasive assessment of left ventricular dyssynchrony by 3-dimensional tissue synchronization imaging in patients with heart failure scheduled for cardiac resynchronization therapy. Am J Cardiol 101 (2008) 1023-1029